Literature DB >> 22572887

Animal models to study gluten sensitivity.

Eric V Marietta1, Joseph A Murray.   

Abstract

The initial development and maintenance of tolerance to dietary antigens is a complex process that, when prevented or interrupted, can lead to human disease. Understanding the mechanisms by which tolerance to specific dietary antigens is attained and maintained is crucial to our understanding of the pathogenesis of diseases related to intolerance of specific dietary antigens. Two diseases that are the result of intolerance to a dietary antigen are celiac disease (CD) and dermatitis herpetiformis (DH). Both of these diseases are dependent upon the ingestion of gluten (the protein fraction of wheat, rye, and barley) and manifest in the gastrointestinal tract and skin, respectively. These gluten-sensitive diseases are two examples of how devastating abnormal immune responses to a ubiquitous food can be. The well-recognized risk genotype for both is conferred by either of the HLA class II molecules DQ2 or DQ8. However, only a minority of individuals who carry these molecules will develop either disease. Also of interest is that the age at diagnosis can range from infancy to 70-80 years of age. This would indicate that intolerance to gluten may potentially be the result of two different phenomena. The first would be that, for various reasons, tolerance to gluten never developed in certain individuals, but that for other individuals, prior tolerance to gluten was lost at some point after childhood. Of recent interest is the concept of non-celiac gluten sensitivity, which manifests as chronic digestive or neurologic symptoms due to gluten, but through mechanisms that remain to be elucidated. This review will address how animal models of gluten-sensitive disorders have substantially contributed to a better understanding of how gluten intolerance can arise and cause disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22572887      PMCID: PMC3410984          DOI: 10.1007/s00281-012-0315-y

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   11.759


  93 in total

1.  T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.

Authors:  O Molberg; S McAdam; K E Lundin; C Kristiansen; H Arentz-Hansen; K Kett; L M Sollid
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

2.  Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes.

Authors:  Fraser W Scott; Paul Rowsell; Gen-Sheng Wang; Karolina Burghardt; Hubert Kolb; Stefanie Flohé
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

3.  Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3.

Authors:  Karen M Lammers; Ruliang Lu; Julie Brownley; Bao Lu; Craig Gerard; Karen Thomas; Prasad Rallabhandi; Terez Shea-Donohue; Amir Tamiz; Sefik Alkan; Sarah Netzel-Arnett; Toni Antalis; Stefanie N Vogel; Alessio Fasano
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682

4.  Genetic susceptibility to gluten sensitive enteropathy in Irish setter dogs is not linked to the major histocompatibility complex.

Authors:  A Polvi; O A Garden; R S Houlston; M Maki; R M Batt; J Partanen
Journal:  Tissue Antigens       Date:  1998-12

5.  Interaction between prostanoids, NO, and VIP in modulation of duodenal alkaline secretion and motility.

Authors:  M Sababi; A Hällgren; O Nylander
Journal:  Am J Physiol       Date:  1996-10

6.  Immunological aspects of nutritional diabetes prevention in NOD mice: a pilot study for the cow's milk-based IDDM prevention trial.

Authors:  W Karges; D Hammond-McKibben; R K Cheung; M Visconti; N Shibuya; D Kemp; H M Dosch
Journal:  Diabetes       Date:  1997-04       Impact factor: 9.461

7.  Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice.

Authors:  J Hoorfar; K Buschard; F Dagnaes-Hansen
Journal:  Br J Nutr       Date:  1993-03       Impact factor: 3.718

8.  Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes.

Authors:  Seiji Yokoyama; Nobumasa Watanabe; Noriko Sato; Pin-Yu Perera; Lyvouch Filkoski; Toshiyuki Tanaka; Masayuki Miyasaka; Thomas A Waldmann; Takachika Hiroi; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-01       Impact factor: 11.205

9.  Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells.

Authors:  T A Fehniger; K Suzuki; A Ponnappan; J B VanDeusen; M A Cooper; S M Florea; A G Freud; M L Robinson; J Durbin; M A Caligiuri
Journal:  J Exp Med       Date:  2001-01-15       Impact factor: 14.307

10.  Transepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaques.

Authors:  Michael T Bethune; Erin Ribka; Chaitan Khosla; Karol Sestak
Journal:  PLoS One       Date:  2008-03-26       Impact factor: 3.240

View more
  7 in total

Review 1.  Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness.

Authors:  Umberto Volta; Giacomo Caio; Francesco Tovoli; Roberto De Giorgio
Journal:  Cell Mol Immunol       Date:  2013-08-10       Impact factor: 11.530

2.  Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.

Authors:  Patricia Alvarez-Sieiro; Maria Cruz Martin; Begoña Redruello; Beatriz Del Rio; Victor Ladero; Brad A Palanski; Chaitan Khosla; Maria Fernandez; Miguel A Alvarez
Journal:  Appl Microbiol Biotechnol       Date:  2014-04-22       Impact factor: 4.813

Review 3.  Are stem cells a potential therapeutic tool in coeliac disease?

Authors:  Rachele Ciccocioppo; Giuseppina Cristina Cangemi; Emanuela Anna Roselli; Peter Kruzliak
Journal:  Cell Mol Life Sci       Date:  2014-12-16       Impact factor: 9.261

Review 4.  Lessons from rodent models in celiac disease.

Authors:  N Korneychuk; B Meresse; N Cerf-Bensussan
Journal:  Mucosal Immunol       Date:  2014-10-29       Impact factor: 7.313

5.  PPARgamma Deficiency Counteracts Thymic Senescence.

Authors:  David Ernszt; Krisztina Banfai; Zoltan Kellermayer; Attila Pap; Janet M Lord; Judit E Pongracz; Krisztian Kvell
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

6.  The intestinal B-cell response in celiac disease.

Authors:  Luka Mesin; Ludvig M Sollid; Roberto Di Niro
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

7.  Society for the Study of Celiac Disease position statement on gaps and opportunities in coeliac disease.

Authors:  M Ines Pinto-Sanchez; Jocelyn A Silvester; Benjamin Lebwohl; Daniel A Leffler; Robert P Anderson; Amelie Therrien; Ciaran P Kelly; Elena F Verdu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-15       Impact factor: 46.802

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.